The utility of thrombophilia testing

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 4, 2014, Pages 495-497

  Franchini, Massimo ^a  

^a CARLO POMA HOSPITAL   (Italy)

Author keywords

Factor V Leiden; inherited thrombophilia; prothrombin mutation; testing

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEIN S; PROTHROMBIN; BLOOD CLOTTING FACTOR 5;

ANTITHROMBIN DEFICIENCY; ARTICLE; HUMAN; IDIOPATHIC DISEASE; MUTATION; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; ANTITHROMBIN III DEFICIENCY; DIAGNOSTIC PROCEDURE; GENETICS;

ANTITHROMBIN III DEFICIENCY; CLINICAL LABORATORY TECHNIQUES; FACTOR V; HUMANS; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOPHILIA;

EID: 84896793701     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0559     Document Type: Article

References (22)

1. Coppola A, Tufano A, Cerbone AM, Di Minno G. Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism. Semin Thromb Hemost 2009;35:683-94.
2. Favaloro EJ, McDonald D, Lippi G. Laboratory investigation of thrombophilia: the good, the bad, and the ugly. Semin Thromb Hemost 2009;35:695-710.
3. Lippi G, Franchini M. Pathogenesis of venous thrombo-embolism: when the cup runneth over. Semin Thromb Hemost 2008;34:747-61.
4. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965;13:516-30.
5. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981;68:1370-3. (Pubitemid 12235040)
6. Comp PC, Esmon CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984;311:1525-8. (Pubitemid 15223250)
7. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004-8. (Pubitemid 23053939)
8. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7. (Pubitemid 24144355)
9. Franchini M. Utility of testing for factor V Leiden. Blood Transfus 2012;10:257-9.
10. Favaloro EJ. Futility of testing for factor V Leiden. Blood Transfus 2012;10:260-3.
11. Rosendaal FR, Reitsma PH. Genetics of venous thombosis. J Thromb Haemost 2009:7(Suppl 1):301-4.
12. Middeldorp S, Levi M. Thrombophilia: an update. Semin Thromb Hemost 2007;33:563-72. (Pubitemid 47429308)
13. Heit JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost 2005;3:1611-7. (Pubitemid 41716546)
14. Dentali F, Sironi AP, Ageno W, Turato S, Bonfanti C, Frattini F, et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost 2012;38:535-48.
15. Wu O, Robertson L, Twaddle S, Lowe G, Clark P, Walker I, et al; Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. Br J Haematol 2005;131: 80-90. (Pubitemid 43899712)
16. Kyrle PA, Rosendaal FR, Eichinger S. Risk assessment for recurrent venous thrombosis. Lancet 2010;376:2032-9.
17. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003;362:523-6. (Pubitemid 36976716)
18. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005;293:2352-61. (Pubitemid 40676757)
19. Vink R, Kraaijenhagen RA, Levi M, Buller HR. Individualized duration of oral anticoagulant therapy for deep vein thrombosis based on a decision model. J Thromb Haemost 2003;1: 2523-30.
20. Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch Intern Med 2006;166:729-36.
21. Brouwer JL, Lijfering LM, ten Kate MI, Kluin-Nelemans HC, Veeger NJ, van der Meer J. High long term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C, or antithrombin. Thromb Haemost 2009;101:93-9.
22. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, et al; Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006;132: 171-96. (Pubitemid 43381552)